Erlotib 150 mg Tablet

Product Description

Erlotib 150 mg Tablet is a targeted therapy specifically designed to combat certain cancers, including non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication works by inhibiting the activity of epidermal growth factor receptor (EGFR) tyrosine kinase, which plays a crucial role in cancer cell growth and survival. By blocking this pathway, Erlotib helps to slow down or stop the proliferation of cancerous cells, potentially leading to improved outcomes for patients. It's important to note that while Erlotib is effective, it may also cause side effects such as skin rash, diarrhea, and fatigue, which should be monitored closely. Patients are advised to undergo regular check-ups to assess their response to treatment and manage any adverse effects promptly. As with any cancer treatment, discussing potential interactions with other medications and existing health conditions with your healthcare provider is essential for safe use. By understanding its function and risks, patients can make informed decisions about incorporating Erlotib into their cancer treatment plan.